• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Infect Dis . Assessing the Impact of SARS-CoV-2 on Influenza-Like Illness Surveillance Trends in the Community during the 2023/2024 Winter in

tetano

Editor, Senior Moderator
Int J Infect Dis


. 2024 Nov 16:107307.
doi: 10.1016/j.ijid.2024.107307. Online ahead of print. Assessing the Impact of SARS-CoV-2 on Influenza-Like Illness Surveillance Trends in the Community during the 2023/2024 Winter in England

Jonathon Mellor[SUP] 1 [/SUP], Martyn Fyles[SUP] 2 [/SUP], Robert S Paton[SUP] 2 [/SUP], Alexander Phillips[SUP] 3 [/SUP], Christopher E Overton[SUP] 4 [/SUP], Thomas Ward[SUP] 2 [/SUP]



Affiliations
Abstract

Background: Influenza-like-illness is a commonly used symptom categorisation in seasonal disease surveillance focusing on influenza in community and clinical settings. However, SARS-CoV-2 often causes presentation with a similar symptom profile. We explore how SARS-CoV-2 positive individuals can influence surveillance trends for WHO, CDC and ECDC influenza-like-illness criteria.
Methods: Harnessing the Winter COVID-19 Infection Study in England, a cohort study, the prevalence of different influenza-like-illness definitions are modelled using multilevel-regression and poststratification using age and spatial stratifications with temporal smoothing. Trends over time across stratifications were compared for SARS-CoV-2 positive and negative individuals to understand differences in influenza-like-illness trends. Symptom presentation across positive and negative SARS-CoV-2 cases were compared.
Results: SARS-CoV-2 symptom profiles are shown to overlap with the influenza-like-illness case definitions, particularly for "cough" and "fever", causing SARS-CoV-2 positive individuals to be frequently detected as influenza-like-illness cases. The trend of SARS-CoV-2 positives is a substantial component of the influenza-like-illness modelled trend driving an earlier perceived peak in prevalence. The ECDC symptom definition was most influenced by SARS-CoV-2 positive individuals.
Conclusion: Using a large community cohort we show how SARS-CoV-2 can impact influenza-like-illness surveillance trends. SARS-CoV-2 makes up a substantial part of the community influenza-like-illness burden and public health messaging should reflect this when discussing influenza-like-illness. We show influenza-like-illness is no longer a strong proxy for influenza activity alone.

Keywords: COVID-19; SARS-CoV-2; influenza; influenza-like-illness; syndromic surveillance.

 
Back
Top Bottom